Corticosteroids for pediatric septic shock patients

Background Septic shock remains a major cause of mortality and admission to the pediatric intensive care unit (PICU) in children. Management includes adequate fluid resuscitation, followed by catecholamine infusion, if needed. Corticosteroid therapy is advised for catecholamine-refractory shock, alt...

Full description

Bibliographic Details
Main Authors: Irene Yuniar, Vembricha Nindya Manusita, Sonya Leonardy Low
Format: Article
Language:English
Published: Indonesian Pediatric Society Publishing House 2019-02-01
Series:Paediatrica Indonesiana
Subjects:
Online Access:https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2058
_version_ 1818024357293719552
author Irene Yuniar
Vembricha Nindya Manusita
Sonya Leonardy Low
author_facet Irene Yuniar
Vembricha Nindya Manusita
Sonya Leonardy Low
author_sort Irene Yuniar
collection DOAJ
description Background Septic shock remains a major cause of mortality and admission to the pediatric intensive care unit (PICU) in children. Management includes adequate fluid resuscitation, followed by catecholamine infusion, if needed. Corticosteroid therapy is advised for catecholamine-refractory shock, although this practice is controversial, as it was not beneficial in other studies. Objective To assess corticosteroid use in pediatric septic shock patients in Cipto Mangunkusumo Hospital. Methods This cross-sectional study included all patients aged 1 month-18 years with a diagnosis of septic shock during the study period of January 2014 to July 2018 admitted in PICU Dr. Cipto Mangunkuskumo Hospital, Jakarta. Data obtained from medical records were, age, sex, immunology status, port d’entrée of sepsis, inotropic and vasopressor usage, mechanical ventilation, corticosteroid type, hospital length of stay (LOS), and mortality outcome. Results Of 217 children with septic shock, 12 patients (5.5%) received corticosteroid therapy. The most common corticosteroid given was hydrocortisone (80%), with a 2 mg/kg BW loading dose, followed by a continuous infusion dose of 2-50 mg/kg BW/day. Almost all patients (11/12) received corticosteroid therapy until they died. Median duration of corticosteroid use was 2 (range 1-7) days, median number of inotropes and vasopressors used was 3 (range 2-4) agents, median LOS was 3 (range 1-9) days, and mortality rate was 100%. Conclusion A small proportion of pediatric septic shock patients received corticosteroid therapy. Their mortality rate was 100%. Further clinical study is needed to evaluate the benefit of corticosteroid therapy in pediatric septic shock patients.
first_indexed 2024-12-10T03:58:56Z
format Article
id doaj.art-7347fd8bf46b44f5a324073414420274
institution Directory Open Access Journal
issn 0030-9311
2338-476X
language English
last_indexed 2024-12-10T03:58:56Z
publishDate 2019-02-01
publisher Indonesian Pediatric Society Publishing House
record_format Article
series Paediatrica Indonesiana
spelling doaj.art-7347fd8bf46b44f5a3240734144202742022-12-22T02:03:02ZengIndonesian Pediatric Society Publishing HousePaediatrica Indonesiana0030-93112338-476X2019-02-01592677110.14238/pi59.2.2019.67-712058Corticosteroids for pediatric septic shock patientsIrene YuniarVembricha Nindya ManusitaSonya Leonardy LowBackground Septic shock remains a major cause of mortality and admission to the pediatric intensive care unit (PICU) in children. Management includes adequate fluid resuscitation, followed by catecholamine infusion, if needed. Corticosteroid therapy is advised for catecholamine-refractory shock, although this practice is controversial, as it was not beneficial in other studies. Objective To assess corticosteroid use in pediatric septic shock patients in Cipto Mangunkusumo Hospital. Methods This cross-sectional study included all patients aged 1 month-18 years with a diagnosis of septic shock during the study period of January 2014 to July 2018 admitted in PICU Dr. Cipto Mangunkuskumo Hospital, Jakarta. Data obtained from medical records were, age, sex, immunology status, port d’entrée of sepsis, inotropic and vasopressor usage, mechanical ventilation, corticosteroid type, hospital length of stay (LOS), and mortality outcome. Results Of 217 children with septic shock, 12 patients (5.5%) received corticosteroid therapy. The most common corticosteroid given was hydrocortisone (80%), with a 2 mg/kg BW loading dose, followed by a continuous infusion dose of 2-50 mg/kg BW/day. Almost all patients (11/12) received corticosteroid therapy until they died. Median duration of corticosteroid use was 2 (range 1-7) days, median number of inotropes and vasopressors used was 3 (range 2-4) agents, median LOS was 3 (range 1-9) days, and mortality rate was 100%. Conclusion A small proportion of pediatric septic shock patients received corticosteroid therapy. Their mortality rate was 100%. Further clinical study is needed to evaluate the benefit of corticosteroid therapy in pediatric septic shock patients.https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2058corticosteroidmortalitypediatric septic shockseptic shock
spellingShingle Irene Yuniar
Vembricha Nindya Manusita
Sonya Leonardy Low
Corticosteroids for pediatric septic shock patients
Paediatrica Indonesiana
corticosteroid
mortality
pediatric septic shock
septic shock
title Corticosteroids for pediatric septic shock patients
title_full Corticosteroids for pediatric septic shock patients
title_fullStr Corticosteroids for pediatric septic shock patients
title_full_unstemmed Corticosteroids for pediatric septic shock patients
title_short Corticosteroids for pediatric septic shock patients
title_sort corticosteroids for pediatric septic shock patients
topic corticosteroid
mortality
pediatric septic shock
septic shock
url https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2058
work_keys_str_mv AT ireneyuniar corticosteroidsforpediatricsepticshockpatients
AT vembrichanindyamanusita corticosteroidsforpediatricsepticshockpatients
AT sonyaleonardylow corticosteroidsforpediatricsepticshockpatients